STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
60 hedge funds and large institutions have $167M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
68% less call options, than puts
Call options by funds: $88K | Put options by funds: $278K
Holders
60
Holding in Top 10
1
Calls
$88K
Puts
$278K
Top Buyers
| 1 | +$4.69M | |
| 2 | +$4.56M | |
| 3 | +$3.05M | |
| 4 |
SC
Samlyn Capital
New York
|
+$2.48M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$1.02M |
Top Sellers
| 1 | -$3.23M | |
| 2 | -$2.96M | |
| 3 | -$1.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.22M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$991K |